Electrochemotherapy with bleomycin in the treatment of hypernephroma metastasis: Case report and literature review

Tumori

Volumn 86, Issue 2, 2000, Pages 163-165

  Serša, Gregor ^a   Čufer, Tanja ^a   Čemažar, Maja ^a   Reberšek, Martina ^a   Zvonimir, Rudolf ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Bleomycin; Electrochemotherapy; Hypernephroma

Indexed keywords

BLEOMYCIN;

ADULT; ARTICLE; CASE REPORT; DRUG DELIVERY SYSTEM; ELECTROCHEMOTHERAPY; HUMAN; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; SKIN METASTASIS; TUMOR VOLUME;

EID: 0034107415     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160008600211     Document Type: Article

References (17)

1. Čemažar M., Miklavčič D., Ščančar J., Dolžan V., Golouh R., Serša G.: Increased platinum accumulation in SA-1 tumor cells after in vivo electrochemotherapy with cisplatin. Br. J. Cancer, 79: 1386-1391, 1999.
2. Heller R., Gilbert R., Jaroszeski M.J.: Clinical applications of electrochemotherapy. Adv. Drug Deliver. Rev., 35: 119-129, 1999.
3. Kubota Y., Mir L.M., Nakada T., Sasagawa I., Suzuki H., Aoyama N.: Succesful treatment of metastatic skin lesions with electrochemotherapy. J. Urol., 160: 1426, 1998.
4. Mir L.M., Banoun H., Paoletti C.: Introduction of definite amount of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp. Cell Res., 175: 15-25, 1988.
5. Mir L.M., Orlowski S., Belehradek J. Jr., Paoletti C.: Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur. J. Cancer, 27: 68-72, 1991.
6. Mir L.M., Glass L.F., Serša G., Teissie J., Domenge C., Miklavčič D., Jaroszeski M.J., Orlowski S., Reintgen D.S., Rudolf Z., Belehradek M., Gilbert R., Rols M.-P., Belehradek J. Jr., Bachaud J.M., DeConti R., Štabuc B., Čemažar M., Coninx P., Heller R.: Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br. J. Cancer., 77: 2336-2342, 1998.
7. Mir L.M., Orlowski S.: Mechanisms of electrochemotherapy. Adv. Drug Deliv. Rev., 35: 107-118, 1999.
8. Panje W.R., Harrell E., Hier M., Goldman A., Garman G.R., Bloch I.: Electroporation therapy of head and neck cancer. Ann. Otol. Rhinol. Laryngol., 107: 779-785, 1998.
9. Poddevin B., Orlowski S., Belehradek J. Jr.,. Mir L.M.: Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol., 42: S67-S75, 1991.
10. Rudolf Z., Štabuc B., Čemažar M., Miklavčič D., Vodovnik L., Serša G.: Electrochemotlierapy with bleomycin: the first clinical experience in malignant melanoma patients. Radiol. Oncol., 29: 229-235, 1995.
11. Serša G., Čemažar M., Miklavčič D.: Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res., 55: 3450-3455, 1995.
12. Serša G., Beravs K., Čemažar M., Miklavčič D., Demšar F: Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro. Magnetobiol., 17: 299-306, 1998.
13. Serša G., Štabuc B., Čemažar M., Jančar B., Miklavčič D., Rudolf Z.: Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur. J. Cancer, 34: 1213-1218, 1998.
14. Serša G., Čemažar M., Parkins C.S., Chaplin D.J.: Tumour blood flow changes induced by application of electric pulses. Eur. J. Cancer, 35: 672-677, 1999.
15. Serša G., Čemažar M., Miklavčič D., Chaplin D.J.: Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res., 19: 4017-4022, 1999.
16. Serša G., Štabuc B., Čemažar M., Miklavčič D, Rudolf Z.: Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin. Cancer Res., 6: 863-867, 2000.
17. Yagoda A., Abi-Rached B., Petrylak D.: Chemotherapy for advanced renal cell carcinoma: 1983-1993. Semin. Oncol., 22: 42-60, 1995.